Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Sep-30-18 | Sep-30-17 |
| Revenues | 5.8 | 1.7 | 1.7 | 2.9 | 1.4 | 1.7 |
| Revenue growth | 253.4% | -3.6% | -41.0% | | -16.9% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 5.8 | 1.7 | 1.7 | 2.9 | 1.4 | 1.7 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 142.0 | 134.8 | 134.9 | 105.4 | 36.2 | 16.0 |
| General and administrative | 31.9 | 31.9 | 35.0 | 39.5 | 22.8 | 9.1 |
| EBITA | -168.0 | -164.9 | -168.1 | -141.9 | -57.5 | -23.4 |
| EBITA margin | -2873.9% | -9970.4% | -9799.1% | -4880.2% | -4089.1% | -1383.2% |
| Amortization of intangibles | 0.1 | 0.1 | 0.1 | 0.0 | | |
| EBIT | -168.0 | -165.0 | -168.1 | -142.0 | -57.5 | -23.4 |
| EBIT margin | -2875.0% | -9975.8% | -9804.4% | -4881.8% | -4089.1% | -1383.2% |
| Pre-tax income | -173.2 | -166.0 | -166.3 | -139.0 | -52.0 | -23.4 |
| Income taxes | -24.4 | -23.9 | -24.2 | 15.2 | -7.3 | 3.7 |
| Tax rate | 14.1% | 14.4% | 14.5% | | 14.0% | |
| Net income | -148.8 | -142.1 | -142.1 | -123.8 | -44.8 | -19.7 |
| Net margin | -2546.4% | -8591.1% | -8285.4% | -4257.2% | -3180.6% | -1163.6% |
| |
| Diluted EPS | ($1.57) | ($1.97) | ($2.76) | ($2.87) | ($1.42) | ($1.43) |
| Shares outstanding (diluted) | 95.0 | 72.1 | 51.6 | 43.1 | 31.6 | 13.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|